Sjögren's Syndrome

Patients with Sjögren’s disease treated with nipocalimab, a novel neonatal Fc receptor blocker, demonstrate significant improvement vs. those who receive placebo at week 24, according to data presented at the EULAR 2024 Congress.

It is essential that rheumatologists aim for “low” or “quiescent” disease activity several months before conception in their patients who desire to become pregnant, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

The risk for hospital-diagnosed COVID-19 among patients with autoimmune or immune-mediated disease may depend on age, specific disease and prior therapy, according to data published in the Annals of the Rheumatic Diseases.

Your patient is back — again. She has presented with red, dry eyes for the last 2 years.

Women aged 18 to 45 years with rheumatic diseases want rheumatologists to play an active role in their sexual and reproductive health, according to findings from a series of interviews published in Arthritis Care & Research.

A phase 4 study set in Israel of a potential treatment for dry eye symptoms related to Sjögren’s syndrome has concluded, Wize Pharma announced in a press release.

An overlapping case of Sjögren’s syndrome can lower the likelihood of achieving remission or low disease activity among patients with rheumatoid arthritis, according to data published in Arthritis Research & Therapy.

Patients with connective tissue disease who maintain their rheumatic therapy do not have an increased risk for COVID-19, according to a group of physicians in Italy who presented findings in an editorial published in the Journal of Rheumatology.

Try your hand at this medical mystery, which is followed by some didactics on a fascinating disease which will hopefully make sense of this inscrutable title.

Aldeyra Therapeutics will prioritize its ocular disease programs while placing on hold clinical development in other fields as part of a strategic prioritization program, according to a press release.